Four Thought Financial, LLC Mirum Pharmaceuticals, Inc. Transaction History
Four Thought Financial, LLC
- $677 Million
- Q3 2022
A detailed history of Four Thought Financial, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Four Thought Financial, LLC holds 780 shares of MIRM stock, worth $36,644. This represents 0.0% of its overall portfolio holdings.
Number of Shares
780
Previous 1,209
35.48%
Holding current value
$36,644
Previous $24,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding MIRM
# of Institutions
211Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$309 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$215 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$152 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$131 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$122 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.73B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...